These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 26840537)

  • 41. DNAM-1/CD155 interactions promote cytokine and NK cell-mediated suppression of poorly immunogenic melanoma metastases.
    Chan CJ; Andrews DM; McLaughlin NM; Yagita H; Gilfillan S; Colonna M; Smyth MJ
    J Immunol; 2010 Jan; 184(2):902-11. PubMed ID: 20008292
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tubulitis in renal allograft rejection: role of transforming growth factor-beta and interleukin-15 in development and maintenance of CD103+ intraepithelial T cells.
    Wong WK; Robertson H; Carroll HP; Ali S; Kirby JA
    Transplantation; 2003 Feb; 75(4):505-14. PubMed ID: 12605119
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Increased Soluble CD226 in Sera of Patients with Cutaneous T-Cell Lymphoma Mediates Cytotoxic Activity against Tumor Cells via CD155.
    Takahashi N; Sugaya M; Suga H; Oka T; Kawaguchi M; Miyagaki T; Fujita H; Inozume T; Sato S
    J Invest Dermatol; 2017 Aug; 137(8):1766-1773. PubMed ID: 28395975
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Laquinimod, a prototypic quinoline-3-carboxamide and aryl hydrocarbon receptor agonist, utilizes a CD155-mediated natural killer/dendritic cell interaction to suppress CNS autoimmunity.
    Ott M; Avendaño-Guzmán E; Ullrich E; Dreyer C; Strauss J; Harden M; Schön M; Schön MP; Bernhardt G; Stadelmann C; Wegner C; Brück W; Nessler S
    J Neuroinflammation; 2019 Feb; 16(1):49. PubMed ID: 30808363
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Renal tubular PD-L1 (CD274) suppresses alloreactive human T-cell responses.
    Starke A; Lindenmeyer MT; Segerer S; Neusser MA; Rüsi B; Schmid DM; Cohen CD; Wüthrich RP; Fehr T; Waeckerle-Men Y
    Kidney Int; 2010 Jul; 78(1):38-47. PubMed ID: 20393451
    [TBL] [Abstract][Full Text] [Related]  

  • 46. NK cells play a significant role in immunosurveillance at the early stage of MLL-AF9 acute myeloid leukemia via CD226/CD155 interactions.
    Wang Y; Chen C; Dong F; Ma S; Xu J; Gong Y; Cheng H; Zhou Y; Cheng T; Hao S
    Sci China Life Sci; 2015 Dec; 58(12):1288-98. PubMed ID: 26588911
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Expression of the DNAM-1 ligands, Nectin-2 (CD112) and poliovirus receptor (CD155), on dendritic cells: relevance for natural killer-dendritic cell interaction.
    Pende D; Castriconi R; Romagnani P; Spaggiari GM; Marcenaro S; Dondero A; Lazzeri E; Lasagni L; Martini S; Rivera P; Capobianco A; Moretta L; Moretta A; Bottino C
    Blood; 2006 Mar; 107(5):2030-6. PubMed ID: 16304049
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Suppression of allograft rejection by CD8+CD122+PD-1+ Tregs is dictated by their Fas ligand-initiated killing of effector T cells versus Fas-mediated own apoptosis.
    Liu H; Wang Y; Zeng Q; Zeng YQ; Liang CL; Qiu F; Nie H; Dai Z
    Oncotarget; 2017 Apr; 8(15):24187-24195. PubMed ID: 28445940
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immunoreceptor TIGIT inhibits the cytotoxicity of human cytokine-induced killer cells by interacting with CD155.
    Zhang B; Zhao W; Li H; Chen Y; Tian H; Li L; Zhang L; Gao C; Zheng J
    Cancer Immunol Immunother; 2016 Mar; 65(3):305-14. PubMed ID: 26842126
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Loss of DNAM-1 ligand expression by acute myeloid leukemia cells renders them resistant to NK cell killing.
    Kearney CJ; Ramsbottom KM; Voskoboinik I; Darcy PK; Oliaro J
    Oncoimmunology; 2016 Aug; 5(8):e1196308. PubMed ID: 27622064
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Renal allograft rejection. Tubular epithelial cells present alloantigen in the presence of costimulatory CD28 antibody.
    Wilson JL; Proud G; Forsythe JL; Taylor RM; Kirby JA
    Transplantation; 1995 Jan; 59(1):91-7. PubMed ID: 7530869
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Expression and possible role of PVR/CD155/Necl-5 in osteoclastogenesis.
    Kakehi S; Nakahama K; Morita I
    Mol Cell Biochem; 2007 Jul; 301(1-2):209-17. PubMed ID: 17286202
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Human cytomegalovirus UL141 promotes efficient downregulation of the natural killer cell activating ligand CD112.
    Prod'homme V; Sugrue DM; Stanton RJ; Nomoto A; Davies J; Rickards CR; Cochrane D; Moore M; Wilkinson GWG; Tomasec P
    J Gen Virol; 2010 Aug; 91(Pt 8):2034-2039. PubMed ID: 20410314
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tumor-derived soluble CD155 inhibits DNAM-1-mediated antitumor activity of natural killer cells.
    Okumura G; Iguchi-Manaka A; Murata R; Yamashita-Kanemaru Y; Shibuya A; Shibuya K
    J Exp Med; 2020 Mar; 217(4):1. PubMed ID: 32040157
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Examination of the TIGIT-CD226-CD112-CD155 Immune Checkpoint Network during a Healthy Pregnancy.
    Meggyes M; Nagy DU; Feik T; Boros A; Polgar B; Szereday L
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142692
    [No Abstract]   [Full Text] [Related]  

  • 56. Expression of DNAM-1 (CD226) on inflammatory monocytes.
    Vo AV; Takenaka E; Shibuya A; Shibuya K
    Mol Immunol; 2016 Jan; 69():70-6. PubMed ID: 26675069
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Natural killer cells play a critical role in mediating inflammation and graft failure during antibody-mediated rejection of kidney allografts.
    Kohei N; Tanaka T; Tanabe K; Masumori N; Dvorina N; Valujskikh A; Baldwin WM; Fairchild RL
    Kidney Int; 2016 Jun; 89(6):1293-306. PubMed ID: 27165816
    [TBL] [Abstract][Full Text] [Related]  

  • 58. CD226 interaction with CD155 impacts on retention and negative selection of CD8 positive thymocytes as well as T cell differentiation to follicular helper cells in Peyer's Patches.
    Danisch S; Qiu Q; Seth S; Ravens I; Dorsch M; Shibuya A; Shibuya K; Förster R; Bernhardt G
    Immunobiology; 2013 Feb; 218(2):152-8. PubMed ID: 22429743
    [TBL] [Abstract][Full Text] [Related]  

  • 59. CD226 and TIGIT Cooperate in the Differentiation and Maturation of Human Tfh Cells.
    Yasutomi M; Christiaansen AF; Imai N; Martin-Orozco N; Forst CV; Chen G; Ueno H
    Front Immunol; 2022; 13():840457. PubMed ID: 35273617
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Impaired alloantigen-mediated T cell apoptosis and failure to induce long-term allograft survival in IL-2-deficient mice.
    Dai Z; Konieczny BT; Baddoura FK; Lakkis FG
    J Immunol; 1998 Aug; 161(4):1659-63. PubMed ID: 9712028
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.